Ritalin, Methylphenidate Newswire

Ritalin, Methylphenidate Newswire

Comprehensive Real-Time News Feed for Ritalin, Methylphenidate (generic).

Results 1 - 20 of 510 in Ritalin, Methylphenidate (generic)

  1. Neos Therapeutics: Third-Quarter Results Point To UpsideRead the original story w/Photo

    7 hrs ago | Seeking Alpha

    In September the FDA approved Adzenys ER and in mid-October Neos announced a confidential settlement and licensing agreement with Actavis which resolved all litigation regarding associated patents. First, I pointed out that the company was poised to penetrate the large yet fragmented $10 billion ADHD market, with Adzenys proving to be an attractive option for both adult and pediatric ADHD patients and their physicians.


  2. The 10 best blogs for ADHDRead the original story w/Photo

    9 hrs ago | Medical News Today

    Blogs that specialize in ADHD can provide educational information, advice, and support for those with the disorder and their friends and family, and tips on day-to-day living with ADHD. We have selected the best blogs for the disorder.


  3. The Ethicist: Can I Let My Friend Pay Off My Mortgages?Read the original story w/Photo

    15 hrs ago | The New York Times

    My closest American friend here in Japan, of more than 30 years, is worried about me and wants to pay off my mortgages. He says he doesn't want to be paid back; he just wants to make sure I am out of debt before he dies.


  4. Meet the new ADHD manRead the original story w/Photo

    Friday Nov 17 | Iol.co.za

    Men's health is in focus this month, and experts are revealing how disorders once perceived as "childhood diseases" such as Attention Deficit Hyperactivity Disorder can have longer lasting effects throughout a man's life if untreated. The misunderstanding of ADHD in adults may have led to many adult men with undiagnosed ADHD never quite achieving their full potential in both professional and personal settings.


  5. NEOS Is Poised To Take Advantage Of Missteps By Pfizer And NovenRead the original story w/Photo

    Thursday Nov 16 | Seeking Alpha

    This likely increases the confidence of NEOS management in meeting their goals, which may contribute to their rejection of PDLI's offer. Authors Note: For this article, in particular, I will disclose that NEOS Therapeutics has marketed two of its drugs directly to me as a Child Psychiatrist, and I anticipate that it will continue to market both drugs directly to me in the future.


  6. KemPharm Completes Successful End-of-Phase 2 Meeting on KP415 with FDARead the original story w/Photo

    Thursday Nov 16 | GlobeNewswire

    KemPharm, Inc. , a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today reported the successful completion of an End-of-Phase 2 meeting with the FDA for KP415, the company's extended release d-methylphenidate prodrug product candidate designed for the treatment of Attention Deficit, Hyperactivity Disorder . KemPharm held the EOP2 meeting with the FDA to discuss the status of the proposed clinical, non-clinical and abuse liability studies, as well as chemistry, manufacturing, and controls programs required for eventual submission of a New Drug Application for KP415.


  7. Take Back Boxes can take back livesRead the original story w/Photo

    Thursday Nov 16 | UnionLeader.com

    It all adds up. Every time government tinkers with New Hampshire's electricity market, the costs end up buried in your electric bill.


  8. Clinical trials review confirms: Omega-3 and omega-6 fatty acids are an effective treatment for ADHDRead the original story w/Photo

    Wednesday Nov 15 | NewsTarget.com

    Polyunsaturated fatty acids could soon be playing a therapeutic role in attention deficit hyperactivity disorder treatments. According to researcher and public health nutritionist Dr. Emma Derbyshire, these fatty acids are "an effective and safe treatment" for this common neurodevelopmental disorder.


  9. Psychostimulant use tied to placental complicationsRead the original story w/Photo

    Wednesday Nov 15 | PhysOrg Weblog

    Psychostimulant use during pregnancy is associated with a small increased relative risk of preeclampsia and preterm birth, according to a study published online Nov. 7 in Obstetrics & Gynecology . Jacqueline M. Cohen, Ph.D., from Brigham and Women's Hospital in Boston, and colleagues examined data from a cohort of pregnant women and their liveborn neonates enrolled in Medicaid to assess whether psychostimulants used to treat attention-deficit/hyperactivity disorder are associated with risk of adverse placental-associated pregnancy outcomes.


  10. Delayed-Release, Extended-Release Formulation Improves Morning and...Read the original story w/Photo

    Monday Nov 13 | The American Journal of Managed Care

    A post hoc analysis of a recent phase 3 trial in children with attention-deficit/hyperactivity disorder treated once daily with a delayed-release and extended-release, long-acting formulation of methylphenidate improved early morning and late afternoon/evening functioning. Existing formulations of methylphenidate used to treat children and adolescents with attention-deficit/hyperactivity disorder are prescribed once daily in the morning.


  11. COMMENTARY: Opioid 'crisis' leading government to disrupt doctor-patient relationshipRead the original story w/Photo

    Saturday Nov 11 | Las Vegas Review Journal

    Of the many horrors that are being inflicted upon this country by opioid drugs, perhaps none is worse than one that is not making headlines. Federal and state agencies have inserted themselves into the doctor-patient relationship like never before.


  12. Connectome-based predictive modeling of attention: Comparing...Read the original story

    Saturday Nov 11 | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. Functional connectivity can predict individual differences in attention.


  13. PDEA destroys P6-B drugs in CaviteRead the original story w/Photo

    Friday Nov 10 | Manila Bulletin

    The Philippine Drug Enforcement Agency destroyed P6 billion worth of dangerous drugs at the Integrated Waste Management Incorporated , Barangay Aguado, Trece Martirez City, Cavite yesterday. Destroyed through thermal decomposition were a total of 952.69 kilograms of assorted pieces of drug evidence composed of methamphetamine hydrochloride , or shabu, cocaine, ketamine, marijuana, benzphetamine HCl, N-benzylpiperazine, zolpidem, ephedrine, propanolol, sodium carbonate, valium, nitrazepam, nalbuphine, clonazepam, alprazolam, midazolam, methylphenidate, MDMA, codeine, pseudoephedrine, and expired medicines; and liquid shabu weighing 1,070,159 ml .


  14. Recent Analysts' Ratings Changes for Neos TherapeuticsRead the original story w/Photo

    Friday Nov 10 | AmericanBankingNews.com

    They now have a "buy" rating on the stock. 10/31/2017 - Neos Therapeutics was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.


  15. KemPharm's (KMPH) CEO Travis Mickle on Q3 2017 Results - Earnings Call TranscriptRead the original story w/Photo

    Thursday Nov 9 | Seeking Alpha

    Good day ladies and gentlemen and welcome to the KemPharm Third Quarter 2017 Corporate Update and Financial Results Conference Call. At this time, all participants are in a listen-only mode.


  16. Hewitt-Trussville student arrested for narcotics possessionRead the original story w/Photo

    Thursday Nov 9 | The Trussville Tribune

    A search of the Hewitt-Trussville High School parking lot by the Trussville Police Department Thursday morning has resulted in the arrest of a 17-year-old HTHS student. Trussville police conducted the search around 9:50 a.m. Thursday morning when the department's K-9 "Leo" indicated on a particular vehicle for the presence of narcotics, according to Detective Michael Bruce.


  17. Omega-3 could treat ADHDRead the original story w/Photo

    Thursday Nov 9 | Daily Mail

    Her meta-analysis revealed the majority of studies reported significant improvement in people with ADHD when treated with omega fatty acids Omega fatty acids are an 'effective and safe treatment' for children with ADHD, a major review of clinical trials has concluded. Omegas, found in oily fish, are important for brain health and learning - and low intakes have been linked with poor social behavior and communication.


  18. Tris Pharma, Inc. v. Actavis Labs. FL, Inc.Read the original story w/Photo

    Wednesday Nov 8 | JD Supra

    Case Name: Tris Pharma, Inc. v. Actavis Labs. FL, Inc. , No. 14-1309-GMS, 2017 U.S. Dist.


  19. Neos Therapeutics Reports Third Quarter 2017 Financial ResultsRead the original story w/Photo

    Wednesday Nov 8 | GlobeNewswire

    Neos Therapeutics, Inc. , a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release products using its proprietary modified-release drug delivery and orally disintegrating tablet technologies, today reported financial results for the third quarter ended September 30, 2017, and provided a business update. "We recently launched our second ADHD product, Cotempla XR-ODTa , and we are very pleased to report that the prescription trends so far are very encouraging.


  20. Many drivers ignore prescription medsRead the original story w/Photo

    Monday Nov 6 | Egypt Today

    One in five drivers in a random survey had taken prescription drugs that could impair their driving ability, and most were on the road despite having been warned about the risks, a U.S. study found. "This is the first large-scale study of prescription drug use at the roadside.